Search Results 741-750 of 18073 for Alopecia

1. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

   Alopecia; Neuropathy resolved to ≤ Grade 2; Congestive heart failure that was ≤ Grade 1 in severity at the time of occurrence and resolved completely. Has ...

2. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   Note: Stable chronic and clinically nonsignificant conditions (≤ Grade 2) that are not expected to resolve (eg, neuropathy, myalgia, alopecia, prior ...

3. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   ... alopecia, vitiligo). Participants with Grade 2 toxicities that are deemed stable or irreversible (e.g., chemotherapy related arthritis or tendinitis, skin ...

4. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

   Not recovered (i.e., to ≤ Grade 1 or to baseline) from AEs emerging from previous treatments (except alopecia or neuropathy). Incomplete recovery from AEs ...

5. A Study of Unesbulin Combined with Dacarbazine to Treat Advanced Leiomyosarcoma (LMS) - Mayo Clinic

   Toxicity from prior therapies recovered to Grade ≤ 1 or subject's baseline, except for alopecia. In addition, endocrinopathies associated with prior ...

6. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

   All ASCT-related toxicities must have recovered to ≤ Grade 1 (except for alopecia, fatigue and amenorrhea) prior to first randomization. Mucositis and ...

7. A Study of STX-0712 in Patients with Advanced Hematologic Malignancies - Mayo Clinic

   ... alopecia, nausea, and fatigue); Clinically significant cardiovascular disease (e.g., uncontrolled or any New York Heart Association class 3 or 4 congestive ...

8. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

9. Mayo Clinic

   Research & Education at Mayo Clinic. Research. Research at Mayo Clinic · Research Faculty · Laboratories · Core Facilities · Centers & Programs.

10. Triamcinolone (topical application route) - Mayo Clinic

    Triamcinolone topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid ( ...